References
- Rantke H. W., Claussner A., Erbes P. M., et al. Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. Blood 1979; 54: 877–884
- Eschbach J. W., Adamson J. W. Anemia of end‐stage renal disease (ESRD). Kidney Int. 1995; 28: 1–5
- Cordova H. R., Benabe J. E., Martinez‐Maldonado M. Clinical manifestations and complications of uremic stage. The Principles and Practice of Nephrology, H. R. Jacobson, G. E. Striker, S. Klahr. B.C. Decker, Inc., Philadelphia 1991; 694
- Lapshina E. A., Zavodnik I. B., Bryszewska M. Effect of free fatty acids on the structure and properties of erythrocyte membrane. Scand. J. Clin. Lab. Invest. 1995; 55: 391–397, [PUBMED], [INFOTRIEVE]
- Athanasiou G. Mechanical and rheological properties of the red blood cell membrane. Doctoral Thesis. 1991, Patras
- Labonia W. D., Morelli O. H., Jr., Gimenez M. I., Freuler P. V., Morelli O. H. Effects of L‐carnitine on sodium transport in erythrocytes from dialyzed uremic patients. Kidney Int. 1987; 32: 754–759, [PUBMED], [INFOTRIEVE]
- Donatelli M., Terrizzi C., Zummo G., Russo V., Bucalo M. L., Scarpinato A. Effects of L‐carnitine on chronic anemia and erythrocyte adenosine triphosphate (ATP) concentration in hemodialysis patients. Curr. Ther. Res. 1987; 41: 620–624
- Sotirakopoulos N., Athanassiou G., Tsitsios T., Stambolidou M., Missirlis Y., Mavromatidis K. Effect of L‐carnitine supplementation on red blood cells deformability in hemodialysis patients. Ren. Fail. 2000; 22: 73–80, [CSA], [CROSSREF]
- Sotirakopoulos N., Athanasiou G., Tsitsios T., Mavromatidis K. The influence of L‐carnitine supplementation on hematoctit and hemoglobin levels in patients with end stage renal failure on CAPD. Ren. Fail. 2002; 24: 505–510, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jendryczko A., Grzeszczak W., Gorczyca E. Increased cholesterol content in erythrocyte membrane of patients with chronic renal failure treated with hemodialysis. Pol. Arch. Med. Wew. 1995; 93: 203–207, [CSA]
- Peuchant E., Salles C., Vallot C., Wone C., Jensen R. Increase of erythrocyte resistance to hemolysis and modification of membrane lipids induced by hemodialysis. Clin. Chim. Acta 1988; 178: 271–282, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shand B. I., Buttimore Al., Lynn K. L., Bailey R. R., Robson R. A. Effect of hemodialysis and recombinant human erythropoietin on determinants of blood viscosity. Ren. Fail. 1994; 16: 407–413, [PUBMED], [INFOTRIEVE], [CSA]
- Novak Z., Buzas E., Salgo L., Gal G. The effect of hemodialysis, using acetate and bicarbonate, on erythrocyte deformability. Orv. Hetil. 1991; 132: 2083–2086, [PUBMED], [INFOTRIEVE]
- Icardi A., Paoletti E., Traverso G. B., Sarchi C., Cappeli G., Molinelli G. Red cell membrane during erythropoietin therapy in hemodialysis and in hemodiafilration. Int. J. Artif. Organs 1991; 14: 147–149, [PUBMED], [INFOTRIEVE]
- Macdougall I. C., Davies M. E., Hutton R. D., Coles G. A., Williams J. D. Rheological studies during treatment of anemia with recombinant human erythropoietin. Br. J. Haematol. 1991; 77: 550–558, [PUBMED], [INFOTRIEVE]